RxDoctor Payments Data

Jordan Pritikin, MD

Plastic Surgery within the Head & Neck · Chicago, ILNPI 1770585259

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.9%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Aerin Medical Inc. accounts for 65.5% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2024 at $35,925 and has fallen 80.8% since, to $6,901 in 2025.

$167,132in general payments, 2019–2025

Across 635 payments — averaging $263.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aerin Medical Inc.$110K
  • Optinose US, Inc.$42K
  • Olympus America Inc.$6K
  • Sanofi$2K
  • Regeneron Healthcare Solutions, Inc.$2K
  • Alk-abello, Inc$1K
  • plus $5K from 20 others
$174,487in research payments, 2019–2025

Across 97 payments — averaging $1798.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Aerin Medical Inc.$165K
  • Stryker$9K
  • Arrinex, Inc.$780

What the payments were for

  • Consulting fees$86,80552%
  • Speaking & faculty fees$53,18532%
  • Travel & lodging$8,4955%
  • Food & beverage$18,47411%
  • Education$1730%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few plastic surgery within the head & neck providers in Illinoisto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$64,003
Medicare patients
166
Services billed
587

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab21$84,209
Ipratropium Bromide59$2,490
Doxycycline Hyclate17$124

Paid to pharmacies, not to this prescriber.

Other plastic surgery within the head & neck in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →